SCHEMBL769803

SCHEMBL769803

O=C(Cc1ccc2ccccc2c1)NCCC(=O)N1CCCC2CCCCC21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
SIGMAR1 Q99720 5/20 0.46
UTS2R Q9UKP6 1/20 0.46
DRD2 P14416 3/20 0.43
DRD3 P35462 2/20 0.43
AIMP2 Q13155 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
DRD4 P21917 1/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
ACKR3 P25106 1/20 0.41
PREP P48147 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL770259 0.87 HSD11B1 (0.59) HSD11B1DRD2SMN1; SMN2NPC1RAB9A
SCHEMBL771660 0.85 DPP4 (0.43) HSD11B1UTS2RDRD2SMN1; SMN2NPC1
SCHEMBL769889 0.81 HSD11B1 (0.57) HSD11B1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL771367 0.79 PREP (0.55) HSD11B1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL770706 0.79 ALDH1A1 (0.44) HSD11B1SIGMAR1DRD2SMN1; SMN2NPC1
SCHEMBL769804 0.78 SIGMAR1 (0.47) SIGMAR1UTS2RDRD2DRD3AIMP2
SCHEMBL771985 0.78 MEN1 (0.53) HSD11B1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL769999 0.77 POLB (0.47) SIGMAR1SMN1; SMN2RAB9AMEN1ALDH1A1
SCHEMBL770920 0.76 RAB9A (0.54) DRD2DRD3SMN1; SMN2NPC1RAB9A
SCHEMBL770599 0.76 DRD3 (0.48) DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885SIGMAR1 3447/4885UTS2R 4507/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885SIGMAR1 3410/4885UTS2R 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.